Suscribirse

Retrospective, multicenter, observational study of 112 surgically treated cases of humerus metastasis - 23/09/20

Doi : 10.1016/j.otsr.2020.02.025 
Aymeric de Geyer a, , Antoine Bourgoin a, Chloé Rousseau b, Mickael Ropars a, Nicolas Bonnevialle c, Charlie Bouthors d, Jules Descamps e, Lucas Niglis f, Fréderic Sailhan e, Paul Bonnevialle c

the SoFCOTg

a Service de chirurgie orthopédique et traumatologique, université de Rennes, CHU de Pontchaillou, 2, rue Henri-Le-Guillou, 35033 Rennes, France 
b Service de santé publique, université de Rennes, CHU de Pontchaillou, 2, rue Henri-Le-Guillou, 35033 Rennes, France 
c Département d’orthopédie traumatologie, hôpital Pierre-Paul-Riquet, place Baylac-Toulouse, 31052 Toulouse cedex, France 
d Service de chirurgie orthopédique, hôpital Bicêtre, AP–HP, 78, rue du Général-Leclerc, 94270 Le-Kremlin-Bicêtre, France 
e Service d’orthopédie traumatologie, hôpital Cochin, 27, rue du Faubourg-St-Jacques, 75014 Paris, France 
f Service hospitalo-universitaire d’orthopédie, traumatologie, hôpital Hautepierre, 1, avenue Molière, 67200 Strasbourg, France 
g Sofcot, 56, rue Boissonade, 75014 Paris, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Introduction

The humerus is the second most common site for metastasis in the peripheral skeleton. These humeral metastases (HM) occur in the midshaft in 42% to 61% of cases and theproximal humerus in 32% to 45% of cases. They are often secondary to primary breast (17–31%), kidney (13–15%) or lung (11–24%) cancer. The optimal surgical treatment between intramedullary (IM) procedures, fixation or arthroplasty is still being debated.

Hypothesis

We hypothesized that fixation and/or arthroplasty are safe and effective options for controlling pain and improving the patients’ function.

Materials and methods

Between 2004 and 2016, 11 French hospitals included 112 continuous cases of HM in 54 men (49%) and 57 women (51%). The average age was 63.7±13.4 years (30–94). The HM occurred in the context of primary breast (30%), lung (23%) or kidney (21%) cancers. The HM was proximal in 35% of cases, midshaft in 59% and distal in 7% of cases. Surgery was required in 69% of patients because of a pathological fracture. The surgical procedure consisted of bundle pinning, plate fixation, arthroplasty or locked IM nailing in 6%, 11%, 14% and 69% of patients, respectively.

Results

Seven patients (6%) had to be reoperated due to surgical site complications including two infections and four fractures (periprosthetic or away from implant). Twelve patients (11%) experienced a general complication. The overall survival was 16.7 months, which was negatively and significantly impacted by the occurrence of a fracture, a diaphyseal location and the type of primary cancer. At the final assessment, 75% had normal or subnormal function and more than 90% were pain-free or had less pain. The final function was not related to the occurrence of a fracture or etiology of the metastasis. In epiphyseal and metaphyseal HM, there was a trend to better function after shoulder arthroplasty than after plate fixation or IM nailing.

Conclusions

Our initial hypothesis was confirmed. Our findings were consistent with those of other published studies. Based on our findings, we recommend using static locked IM nailing with cementoplasty for mid-shaft lesions and modular arthroplasty for destructive epiphyseal or metaphyso–epiphyseal lesions. The criteria for assessing humeral fracture risk should be updated to allow the introduction of a preventative procedure, which contributes to better survival.

Level of evidence

IV, retrospective study.

El texto completo de este artículo está disponible en PDF.

Keywords : Humeral metastasis, Pathological fracture, Cementoplasty, Nailing, Shoulder arthroplasty


Esquema


© 2020  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 6

P. 1047-1057 - octobre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Surgical treatment of tibial metastases: Retrospective, multicenter, observational study of 25 patients
  • Paul Bonnevialle, Jules Descamps, Lucas Niglis, Marie Lebaron, Julie Falguieres, Olivier Mericq, Thierry Fabre, Nicolas Reina, Frédéric Sailhan, members of the SoFCOT
| Artículo siguiente Artículo siguiente
  • Tumor-associated mortality and prognostic factors in myxofibrosarcoma – A retrospective review of 109 patients
  • Magdalena M. Gilg, Sandra Sunitsch, Lukas Leitner, Marko Bergovec, Joanna Szkandera, Andreas Leithner, Bernadette Liegl-Atzwanger

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.